Systematic Review
Accepted on 15 Jan 2025
Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis
in Cancer Immunity and Immunotherapy